David Shaw’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

David Shaw’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-76,000	Closed	-$866K	–	3993
2018 Q4	$866K	Hold	76,000	–	–	﹤0.01%	2755
2018 Q3	$1.65M	Buy	76,000 +16,000	+27%	+$335K	﹤0.01%	2343
2018 Q2	$1.06M	Buy	+60,000	New	+$1.22M	﹤0.01%	2669

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.16B AUM 18.64% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

David Shaw's ITCI Position: Q2 2025 in Review

David Shaw sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 923,809 shares — an estimated $122M sold.

David Shaw first reported a position in ITCI in Q2 2015 and held it in 36 quarters. The position peaked at $122M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

David Shaw reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
David Shaw sold 923,809 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $122M.
David Shaw first reported a position in Intra-Cellular Therapies Inc. in Q2 2015 and held it in 36 quarters.
David Shaw's Intra-Cellular Therapies Inc. position peaked at $122M in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.